|
FGD6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.80457903964771E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68140000000871E-06 |
| Normal-vs-Stage2 |
1.111600E-02 |
| Normal-vs-Stage3 |
3.62799999999996E-05 |
| Normal-vs-Stage4 |
2.652400E-02 |
| Stage1-vs-Stage2 |
2.089200E-01 |
| Stage1-vs-Stage3 |
9.641800E-02 |
| Stage1-vs-Stage4 |
2.579400E-01 |
| Stage2-vs-Stage3 |
9.274000E-01 |
| Stage2-vs-Stage4 |
9.104800E-01 |
| Stage3-vs-Stage4 |
9.439000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.76059997084133E-09 |
| Normal-vs-AfricanAmerican |
2.14969999999814E-05 |
| Normal-vs-Asian |
3.704800E-01 |
| Caucasian-vs-AfricanAmerican |
4.409400E-01 |
| Caucasian-vs-Asian |
4.551600E-01 |
| AfricanAmerican-vs-Asian |
3.217200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.54279999676055E-09 |
| Normal-vs-Female |
8.88460000014746E-08 |
| Male-vs-Female |
7.096400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.373700E-04 |
| Normal-vs-Extreme_Weight |
9.8587999999955E-05 |
| Normal-vs-Obese |
1.67099999948128E-07 |
| Normal-vs-Extreme_Obese |
4.372000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.719400E-01 |
| Normal_Weight-vs-Obese |
8.817900E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.601800E-02 |
| Extreme_Weight-vs-Obese |
1.034400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.753500E-02 |
| Obese-vs-Extreme_Obese |
3.997600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.596900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.52110554654905E-11 |
| Normal-vs-Age(61-80Yrs) |
6.3724999999959E-05 |
| Normal-vs-Age(81-100Yrs) |
9.977300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.386030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.721700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.302700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.678000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.723900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.601200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.29050000019504E-07 |
| Normal-VS-Type2 PRCC |
3.16339999972826E-07 |
| Normal-VS-KIRP CIMP |
8.040200E-04 |
| Normal-VS-Unclassified PRCC |
1.631820E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.371600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.698260E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.512400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.172740E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.829410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.564400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.81669999999423E-05 |
| Normal-vs-N1 |
2.959100E-03 |
| Normal-vs-N2 |
1.41939793252277E-11 |
| N0-vs-N1 |
3.276500E-02 |
| N0-vs-N2 |
1.017340E-03 |
| N1-vs-N2 |
7.593400E-01 |
|
|
